HCA, one of the largest for-profit hospital operators in the U.S., reported a net income of nearly $1.5 billion in the second quarter of 2024, up from $1.2 billion over the same period a year earlier.
Below are four HCA executives’ stock transaction activities since July 25, according to the SEC filings:
1. Chris Wyatt, senior vice president and controller, sold 4,000 shares of the company’s stock on July 29 for a total price of $1,440,783.
2. Kathi Whalen, senior vice president and chief ethics and compliance officer, sold 1,864 shares of the company’s stock July 29 for a total price of $670,890.88.
3. Deborah Reiner, senior vice president of marketing and corporate affairs, sold 3,314 shares of the company’s stock July 29 for a total price of $1,192,914.40.
4. Kathryn Torres, senior vice president of payer contracting and alignment, sold 1,857 shares of the company’s stock July 25 for a total price of $659,327.85.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
